by adminmps | Apr 5, 2023 | News
$1.5 Billion Canadian National Strategy for Drugs for Rare Diseases The Health Minister Jean-Yves Duclos announced measures in support of the first-ever National Strategy for Drugs for Rare Diseases, with an investment of up to $1.5 billion over three years. This will...
by adminmps | Apr 4, 2023 | Clinical Trials, News
Takeda has announced a Post-Trial Access program for patients currently enrolled in extension trials for TAK-609, a treatment for MPS II Hunter syndrome. This program will provide continued access for patients who have benefited from treatment on existing studies....
by adminmps | Mar 30, 2023 | Uncategorized
Join us at We Care – a Gathering for Parents and Caregivers. Following great feedback from the last We Care – a Gathering for Parents and Caregivers, online session for our members: the Canadian MPS Society are pleased to host another on March 15,...
by adminmps | Feb 27, 2023 | Uncategorized
Join us at We Care – a Gathering for Parents and Caregivers. Following great feedback from the last We Care – a Gathering for Parents and Caregivers, online session for our members: the Canadian MPS Society are pleased to host another on March 15,...
by adminmps | Jan 4, 2023 | Uncategorized
a Gathering for MPS Parents and Caregivers Save your spot for the first parent/caregiver get-together of the new year! Join us on Wednesday, 25 January, 2023. The Canadian MPS Society continues to host a series of online get togethers, facilitated by Angie Lombardo,...
